Best VCs for Digital Health

541 venture capitalists actively investing in Digital Health.

541
Active VCs
0
Funds
0
Deals
#1Bryan Rosenblatt

Venture Partner

Craft Ventures

Bryan applies a growth, revenue, and marketplace lens shaped by building Reddit's New York revenue organization and Twitter's startup advertising business. His investments favor products that remove e

No personal check-size range is published. Craft invests from angel/seed through venture and growth; amounts in Bryan's investment announcements are total company rounds, not his personal or standard Craft checks.
AngelPre-SeedSeed
#2Alex Morgan

Partner

Khosla Ventures

Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicin

No personal check range is published. Khosla's Seed Fund supports science and business-model experiments, historically often with roughly $1M–$2M according to a 2020 firm interview, while its Main Fund covers early through later stages. These are firm-level references, not Alex's authority.
IncubationPre-SeedSeed
#3Jun Wakabayashi

Venture Principal

AppWorks

Jun uses fund investments as ecosystem infrastructure: back locally connected or specialist managers, exchange market intelligence and diligence, create co-investment and follow-on capital paths, and

Not publicly disclosed for Beacon Funds commitments. AppWorks' direct-company strategy publishes US$200K to US$15M per deal from Seed through Series C; that range should not be applied to Jun's venture-fund investments.
Emerging ManagersVenture FundsSeed
#4Arielle Rothman

Investor

BoxGroup

Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-dev

No reliable Arielle-specific check size is public. BoxGroup describes itself as an earliest-stage investor, but founders should confirm current round fit and allocation directly rather than relying on third-party range estimates.
Pre-seedSeedEarliest-stage company formation
#5Deena Shakir

Partner

Lux Capital

Deena backs transformative technologies that improve health, access and economic opportunity, often with extraordinary underdog founders attacking problems conventional pattern recognition overlooks.

Lux does not publish a dependable personal check range for Deena. Her investments span stages, including first institutional rounds and later healthcare financings; founders should confirm vehicle, initial ticket, ownership, reserves and stage fit with the partnership.
SeedSeries ASeries B
#6Jackie Vullinghs

Partner

AirTree Ventures (Web3)

Jackie backs Australia and New Zealand founders from very early product formation through scale. Her disclosed portfolio crosses AI and enterprise software, healthcare, fintech, consumer platforms, fu

Neither Airtree nor Jackie publishes her personal check range or decision authority. The firm is seed-first and supports companies through later stages; individual portfolio round totals do not reveal Airtree's allocation or Jackie's authority.
Pre-SeedSeedSeries A
#7Fanis Tsarouchis

Senior Principal

Big Pi Ventures

Fanis supports European technology scale-ups moving toward market leadership with growth capital plus operational and financial expertise. His background in TMT investment banking and as FlexCar's fin

Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Big Pi's overall platform spans €0.5M–€30M across funds. Neither range is published as Fanis's personal allocation authority.
Series BSeries CGrowth Equity
#8Wendy Xiao

Partner

Northzone (Web3)

Wendy backs companies that change consumer behavior and expand the economic pie by capturing neglected externalities. She studies technology through people and behavior change, looking for a valuable

Not publicly disclosed. Northzone states that the firm invests from Seed through Growth and can remain a partner through pre-IPO; Wendy's current profile labels her personal focus as Early and says she likes to work with founders from as early as seed.
SeedSeries AEarly Stage
#9Panos Metsis

Partner

Big Pi Ventures

Panos leads growth investments in European technology companies that already show category leadership and can use €7M–€20M+ plus active operating support to scale internationally. His recent work emph

Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Panos focuses on Series B+ growth investments; the published fund range is not a guarantee of his personal allocation authority for any deal.
Series BSeries CGrowth Equity
#10Joe Amaral, MD

Chief Medical and Scientific Officer

Clarevia

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#11Paul Weiss

Partner

Clarevia

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and de

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#12Jim Adox

Managing Partner

Clarevia

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#13Joslin Owens

Director of Finance

7wire Ventures

Joslin Owens is listed in a Director of Finance capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#14John Neis

Partner

Clarevia

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and dev

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#15David Arnstein

Partner and Chief Financial Officer

Clarevia

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared c

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#16Jenni Le

Principal

Clarevia

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#17Insoo Chang

Principal

Tau Ventures

Insoo Chang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#18Amit Garg

Founding Partner

Tau Ventures

Amit Garg invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#19Sam Bogrov

Principal

Tau Ventures

Sam Bogrov invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#20Sanjay Rao

Founding Partner

Tau Ventures

Sanjay Rao invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#21Bruce Broussard

Venture Partner

Define Ventures

Bruce Broussard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dr

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#22David Schonthal

Operating Partner

7wire Ventures

David Schonthal is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction an

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#23Larry Augustin

Venture Partner

Tau Ventures

Larry Augustin invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technolog

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#24Sonal Panda

Advisory Partner

Tau Ventures

Sonal Panda is listed in a Advisory Partner capacity at Tau Ventures. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#25Karsten Vagner

Head of People

Define Ventures

Karsten Vagner is listed in a Head of People capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#26Scott Button

Partner

Clarevia

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#27Katharine Morris

Administrative Assistant & Office Manager

Define Ventures

Katharine Morris is listed in a Administrative Assistant & Office Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included onl

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#28Sathya Shanthakumar

Director of Investor Relations

7wire Ventures

Sathya Shanthakumar is listed in a Director of Investor Relations capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that ro

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#29Vivek Ranadivé

Founder and Managing Director

Bow Capital

Vivek Ranadivé is listed in a Founder and Managing Director capacity at Bow Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#30Disha Karale

Investor

BoxGroup

Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastr

BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.
Pre-SeedSeedSeries A
#31Sharon Huang

Principal

Tau Ventures

Sharon Huang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologie

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#32Kayla Liederbach

Fractional Head of Marketing

HealthX Ventures

Kayla Liederbach contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and s

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#33Laura Hilty

Principal

HealthX Ventures

Laura Hilty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#34Fahad Qureshi

Vice President, Accounting and Finance

OCA Ventures

Fahad Qureshi is listed in a Vice President, Accounting and Finance capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that ro

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#35Shannon Flaherty

VP, Operations & Compliance

HealthX Ventures

Shannon Flaherty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and s

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#36Emma Merrick

Associate

HealthX Ventures

Emma Merrick contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndi

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#37Adina Davis

Partner

BoxGroup

Adina is an early-stage generalist with a publicly documented emphasis on B2B software, consumer internet, and fintech. Her operating background in e-commerce and recent visible interest in AI deploym

BoxGroup publicly invests up to $1M. Older third-party profiles place Adina's typical early-stage range around $250K–$500K, but founders should treat the firm's current $1M ceiling—not an old personal range—as authoritative.
Pre-SeedSeedSeries A
#38Alexis Johnson

Chief of Staff

HealthX Ventures

Alexis Johnson contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syn

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#39Stefano Guidotti

Partner

P101

Stefano Guidotti invests or supports investment work through P101. P101's published strategy is to partner early and for the long term with bold, resilient founders building technology companies that

P101 does not publish one standard current check-size range on its official site.
SeedSeries AEarly Growth
#40Mark Bakken

Managing Partner

HealthX Ventures

Mark Bakken contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#41Roy Rosin

Board Partner

First Round Capital

Roy spends most of his First Round time in healthcare, applying three decades of product, innovation, and care-delivery experience to companies that can materially improve lives. He favors practical e

Firm-level: First Round says initial investments typically range from $1M-$7M, average about $3.5M, and have ranged below and above that; participating rounds have ranged from $100K-$20M.
Pre-SeedSeed
#42Lynne Chou O'Keefe

Founder & Managing Partner

Define Ventures

Lynne Chou O'Keefe invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#43Tejas Vijh

Associate

Boomerang Ventures

Tejas Vijh invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#44Frank Williams

Venture Partner

Define Ventures

Frank Williams invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dri

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#45Carolyn Magill

Venture Partner

Define Ventures

Carolyn Magill invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-dri

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#46Tom Richards

Operating Partner

7wire Ventures

Tom Richards is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#47Liz Todia Zambory

Principal

Mutual Capital Partners

Liz Todia Zambory invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that ha

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#48Darcey Nett

Partner

HealthX Ventures

Darcey Nett contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndic

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#49Claire Smilow

Partner

BoxGroup

Claire backs formation-stage technology companies as a BoxGroup generalist, with visible strength across enterprise and developer software, AI-native products, consumer experiences, and marketplaces.

BoxGroup publicly invests up to $1M. Some third-party directories show an older $250K–$500K personal range, but no current primary source confirms a separate personal allocation.
Pre-SeedSeedSeries A
#50Ravi Varma

Venture Partner

Tau Ventures

Ravi Varma invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies,

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#51Claire Sun

Associate

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#52Shannon Knous

VP of Finance & Operations

Define Ventures

Shannon Knous is listed in a VP of Finance & Operations capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared contex

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#53Lauren O'Mahony

Head of Marketing

Define Ventures

Lauren O'Mahony is listed in a Head of Marketing capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
IncubationSeedSeries A
#54Cameron Raglin

Senior Associate

7wire Ventures

Cameron Raglin invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and

7wire Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#55Allison Weiland

Finance and Operations Manager

Tamarind Hill

Allison Weiland is listed in a Finance and Operations Manager capacity at Tamarind Hill. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role di

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#56Glenda Grazioli

Partner

P101

Glenda Grazioli invests or supports investment work through P101. P101's published strategy is to partner early and for the long term with bold, resilient founders building technology companies that c

P101 does not publish one standard current check-size range on its official site.
SeedSeries AEarly Growth
#57Alex Shandiz

General Partner

Boomerang Ventures

Alex Shandiz invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#58Ariel MacTavish

Venture Partner

Boomerang Ventures

Ariel MacTavish invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#59Audrey Beckman

Partner and Chief Innovation Officer

Boomerang Ventures

Audrey Beckman invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#60Dick Aderman

Studio Director

Boomerang Ventures

Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#61Oscar Moralez

Founder and Managing Partner

Boomerang Ventures

Oscar Moralez invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and p

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#62Todd R. Lugar

Controller and HR Lead

Boomerang Ventures

Todd R. Lugar is listed in a Controller and HR Lead capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinc

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#63Samantha McGrandy

Chief Financial Officer

HealthX Ventures

Samantha McGrandy contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#64Christie Currie

Senior Associate

Tamarind Hill

Christie Currie invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#65Josh Buehler

Operating Partner

Tamarind Hill

Josh Buehler invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care eco

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#66Ben Trumbull

Managing Partner

Tamarind Hill

Ben Trumbull invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care eco

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#67Tony Petrucciani

Partner and Chief Financial Officer

Boomerang Ventures

Tony Petrucciani is listed in a Partner and Chief Financial Officer capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves t

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#68Bob Saunders

General Partner

OCA Ventures

Bob Saunders invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#69Nick Schoewe

Vice Chairman and General Partner

OCA Ventures

Nick Schoewe invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#70Kevin McQuillan

General Partner

OCA Ventures

Kevin McQuillan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#71Murray Rode

General Partner

Bow Capital

Murray Rode invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, u

$5M average investment into core companies, as published by Bow Capital.
SeedSeries A
#72Michelle Cao

Vice President, Investments

OCA Ventures

Michelle Cao invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#73Manu Sharma

Vice President, Investments

OCA Ventures

Manu Sharma invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#74Kelley Quinn

Finance and Operations Manager

OCA Ventures

Kelley Quinn is listed in a Finance and Operations Manager capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#75Waverly Deutsch

Operating Partner

OCA Ventures

Waverly Deutsch invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#76Peter Ianlo

Chairman and Co-Founder

OCA Ventures

Peter Ianlo invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#77Sarah Manasevit

Senior Associate

OCA Ventures

Sarah Manasevit invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#78Leticia Martinez

Senior Executive Assistant

OCA Ventures

Leticia Martinez is listed in a Senior Executive Assistant capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distin

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#79Brian Lindstrom

Partner

HealthX Ventures

Brian Lindstrom contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and sy

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#80Bill Trainor

Co-Founder and Partner

Mutual Capital Partners

Bill Trainor invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have st

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#81Wayne Wallace

Co-Founder and Partner

Mutual Capital Partners

Wayne Wallace invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have s

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#82Ally Thill

Project Leader

Boomerang Ventures

Ally Thill is listed in a Project Leader capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and us

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#83Ian Drury

Venture Partner

OCA Ventures

Ian Drury invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#84Dan Clark

Venture Partner

Boomerang Ventures

Dan Clark invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patie

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#85David Helmer

Partner

Boomerang Ventures

David Helmer invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pa

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#86Eric Beier

Partner and Chief Medical Officer

Boomerang Ventures

Eric Beier invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and pati

Boomerang Ventures does not publish a standard current check-size range on its official site.
Pre-SeedSeedSeries A
#87Dan Neill

Venture Consultant

HealthX Ventures

Dan Neill contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicat

HealthX Ventures does not publish a standard check-size range on its current official website.
Pre-RevenueSeedEarly Stage
#88Mark Shary

Managing Partner

Tamarind Hill

Mark Shary invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care econo

$2M-$7M seed rounds, as published by Tamarind Hill.
SeedEarly Stage
#89Jim Dugan

Founding Managing Partner

OCA Ventures

Jim Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#90Steve Shein

Principal

OCA Ventures

Steve Shein invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cust

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#91John Dugan

Chairman Emeritus and Co-Founder

OCA Ventures

John Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custo

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#92Dave Zyer

Venture Partner

OCA Ventures

Dave Zyer invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early custom

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#93John Barnard

MBA Intern

OCA Ventures

John Barnard invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early cus

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#94Rashika Rahman

Intern

OCA Ventures

Rashika Rahman invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early c

$1M-$3M with follow-on capacity, as published by OCA Ventures.
SeedSeries ASeries B
#95Gary Ang

Venture Partner

Tau Ventures

Gary Ang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, w

Tau Ventures does not publish a standard current check-size range on its live official site.
Pre-SeedSeedGrowth
#96Will Brune

Senior Associate

Mutual Capital Partners

Will Brune invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have stro

Mutual Capital Partners does not publish a standard current check-size range on its official site.
Early StageGrowth
#97Pamela York

Founder and Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#98Sara Russick

Founder and Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#99Kathy Tune

Managing Partner

Capita3

At the firm level, Capita3 backs exceptional teams commercializing science- and evidence-backed deep technology, digital health, and healthcare innovation.

Not publicly specified on the official site
Pre-seedSeedSeries A
#100Margaret Kaczor Andrew

Venture Partner

Clarevia

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therap

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth

Explore more sectors

All SectorsDigital Health InvestmentsAll VCs